Cargando…

Hematoma enlargement characteristics in deep versus lobar intracerebral hemorrhage

OBJECTIVE: Hematoma enlargement (HE) is associated with clinical outcomes after supratentorial intracerebral hemorrhage (ICH). This study evaluates whether HE characteristics and association with functional outcome differ in deep versus lobar ICH. METHODS: Pooled analysis of individual patient data...

Descripción completa

Detalles Bibliográficos
Autores principales: Sembill, Jochen A., Kuramatsu, Joji B., Gerner, Stefan T., Sprügel, Maximilian I., Roeder, Sebastian S., Madžar, Dominik, Hagen, Manuel, Hoelter, Philip, Lücking, Hannes, Dörfler, Arnd, Schwab, Stefan, Huttner, Hagen B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086015/
https://www.ncbi.nlm.nih.gov/pubmed/32133793
http://dx.doi.org/10.1002/acn3.51001
_version_ 1783509050172899328
author Sembill, Jochen A.
Kuramatsu, Joji B.
Gerner, Stefan T.
Sprügel, Maximilian I.
Roeder, Sebastian S.
Madžar, Dominik
Hagen, Manuel
Hoelter, Philip
Lücking, Hannes
Dörfler, Arnd
Schwab, Stefan
Huttner, Hagen B.
author_facet Sembill, Jochen A.
Kuramatsu, Joji B.
Gerner, Stefan T.
Sprügel, Maximilian I.
Roeder, Sebastian S.
Madžar, Dominik
Hagen, Manuel
Hoelter, Philip
Lücking, Hannes
Dörfler, Arnd
Schwab, Stefan
Huttner, Hagen B.
author_sort Sembill, Jochen A.
collection PubMed
description OBJECTIVE: Hematoma enlargement (HE) is associated with clinical outcomes after supratentorial intracerebral hemorrhage (ICH). This study evaluates whether HE characteristics and association with functional outcome differ in deep versus lobar ICH. METHODS: Pooled analysis of individual patient data between January 2006 and December 2015 from a German‐wide cohort study (RETRACE, I + II) investigating ICH related to oral anticoagulants (OAC) at 22 participating centers, and from one single‐center registry (UKER‐ICH) investigating non‐OAC‐ICH patients. Altogether, 1954 supratentorial ICH patients were eligible for outcome analyses, which were separately conducted or controlled for OAC, that is, vitamin‐K‐antagonists (VKA, n = 1186) and non‐vitamin‐K‐antagonist‐oral‐anticoagulants (NOAC, n = 107). Confounding was addressed using propensity score matching, cox regression modeling and multivariate modeling. Main outcomes were occurrence, extent, and timing of HE (>33%/>6 mL) and its association with 3‐month functional outcome. RESULTS: Occurrence of HE was not different after deep versus lobar ICH in patients with non‐OAC‐ICH (39/356 [11.0%] vs. 36/305 [11.8%], P = 0.73), VKA‐ICH (249/681 [36.6%] vs. 183/505 [36.2%], P = 0.91), and NOAC‐ICH (21/69 [30.4%] vs. 12/38 [31.6%], P = 0.90). HE extent did not differ after non‐OAC‐ICH (deep:+59% [40–122] vs. lobar:+74% [37–124], P = 0.65), but both patients with VKA‐ICH and NOAC‐ICH showed greater HE extent after deep ICH [VKA‐ICH, deep: +94% [54–199] vs. lobar: +56% [35–116], P < 0.001; NOAC‐ICH, deep: +74% [56–123] vs. lobar: +40% [21–49], P = 0.001). Deep compared to lobar ICH patients had higher HE hazard during first 13.5 h after onset (Hazard ratio [HR]: 1.85 [1.03–3.31], P = 0.04), followed by lower hazard (13.5–26.5 h, HR: 0.46 [0.23–0.89], P = 0.02), and equal hazard thereafter (HR: 0.96 [0.56–1.65], P = 0.89). Odds ratio for unfavorable outcome was higher after HE in deep (4.31 [2.71–6.86], P < 0.001) versus lobar ICH (2.82 [1.71–4.66], P < 0.001), and only significant after small‐medium (1st volume‐quarter, deep: 3.09 [1.52–6.29], P < 0.01; lobar: 3.86 [1.35–11.04], P = 0.01) as opposed to large‐sized ICH (4th volume‐quarter, deep: 1.09 [0.13–9.20], P = 0.94; lobar: 2.24 [0.72–7.04], P = 0.17). INTERPRETATION: HE occurrence does not differ among deep and lobar ICH. However, compared to lobar ICH, HE after deep ICH is of greater extent in OAC‐ICH, occurs earlier and may be of greater clinical relevance. Overall, clinical significance is more apparent after small–medium compared to large‐sized bleedings.
format Online
Article
Text
id pubmed-7086015
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-70860152020-03-24 Hematoma enlargement characteristics in deep versus lobar intracerebral hemorrhage Sembill, Jochen A. Kuramatsu, Joji B. Gerner, Stefan T. Sprügel, Maximilian I. Roeder, Sebastian S. Madžar, Dominik Hagen, Manuel Hoelter, Philip Lücking, Hannes Dörfler, Arnd Schwab, Stefan Huttner, Hagen B. Ann Clin Transl Neurol Research Articles OBJECTIVE: Hematoma enlargement (HE) is associated with clinical outcomes after supratentorial intracerebral hemorrhage (ICH). This study evaluates whether HE characteristics and association with functional outcome differ in deep versus lobar ICH. METHODS: Pooled analysis of individual patient data between January 2006 and December 2015 from a German‐wide cohort study (RETRACE, I + II) investigating ICH related to oral anticoagulants (OAC) at 22 participating centers, and from one single‐center registry (UKER‐ICH) investigating non‐OAC‐ICH patients. Altogether, 1954 supratentorial ICH patients were eligible for outcome analyses, which were separately conducted or controlled for OAC, that is, vitamin‐K‐antagonists (VKA, n = 1186) and non‐vitamin‐K‐antagonist‐oral‐anticoagulants (NOAC, n = 107). Confounding was addressed using propensity score matching, cox regression modeling and multivariate modeling. Main outcomes were occurrence, extent, and timing of HE (>33%/>6 mL) and its association with 3‐month functional outcome. RESULTS: Occurrence of HE was not different after deep versus lobar ICH in patients with non‐OAC‐ICH (39/356 [11.0%] vs. 36/305 [11.8%], P = 0.73), VKA‐ICH (249/681 [36.6%] vs. 183/505 [36.2%], P = 0.91), and NOAC‐ICH (21/69 [30.4%] vs. 12/38 [31.6%], P = 0.90). HE extent did not differ after non‐OAC‐ICH (deep:+59% [40–122] vs. lobar:+74% [37–124], P = 0.65), but both patients with VKA‐ICH and NOAC‐ICH showed greater HE extent after deep ICH [VKA‐ICH, deep: +94% [54–199] vs. lobar: +56% [35–116], P < 0.001; NOAC‐ICH, deep: +74% [56–123] vs. lobar: +40% [21–49], P = 0.001). Deep compared to lobar ICH patients had higher HE hazard during first 13.5 h after onset (Hazard ratio [HR]: 1.85 [1.03–3.31], P = 0.04), followed by lower hazard (13.5–26.5 h, HR: 0.46 [0.23–0.89], P = 0.02), and equal hazard thereafter (HR: 0.96 [0.56–1.65], P = 0.89). Odds ratio for unfavorable outcome was higher after HE in deep (4.31 [2.71–6.86], P < 0.001) versus lobar ICH (2.82 [1.71–4.66], P < 0.001), and only significant after small‐medium (1st volume‐quarter, deep: 3.09 [1.52–6.29], P < 0.01; lobar: 3.86 [1.35–11.04], P = 0.01) as opposed to large‐sized ICH (4th volume‐quarter, deep: 1.09 [0.13–9.20], P = 0.94; lobar: 2.24 [0.72–7.04], P = 0.17). INTERPRETATION: HE occurrence does not differ among deep and lobar ICH. However, compared to lobar ICH, HE after deep ICH is of greater extent in OAC‐ICH, occurs earlier and may be of greater clinical relevance. Overall, clinical significance is more apparent after small–medium compared to large‐sized bleedings. John Wiley and Sons Inc. 2020-03-04 /pmc/articles/PMC7086015/ /pubmed/32133793 http://dx.doi.org/10.1002/acn3.51001 Text en © 2020 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Sembill, Jochen A.
Kuramatsu, Joji B.
Gerner, Stefan T.
Sprügel, Maximilian I.
Roeder, Sebastian S.
Madžar, Dominik
Hagen, Manuel
Hoelter, Philip
Lücking, Hannes
Dörfler, Arnd
Schwab, Stefan
Huttner, Hagen B.
Hematoma enlargement characteristics in deep versus lobar intracerebral hemorrhage
title Hematoma enlargement characteristics in deep versus lobar intracerebral hemorrhage
title_full Hematoma enlargement characteristics in deep versus lobar intracerebral hemorrhage
title_fullStr Hematoma enlargement characteristics in deep versus lobar intracerebral hemorrhage
title_full_unstemmed Hematoma enlargement characteristics in deep versus lobar intracerebral hemorrhage
title_short Hematoma enlargement characteristics in deep versus lobar intracerebral hemorrhage
title_sort hematoma enlargement characteristics in deep versus lobar intracerebral hemorrhage
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086015/
https://www.ncbi.nlm.nih.gov/pubmed/32133793
http://dx.doi.org/10.1002/acn3.51001
work_keys_str_mv AT sembilljochena hematomaenlargementcharacteristicsindeepversuslobarintracerebralhemorrhage
AT kuramatsujojib hematomaenlargementcharacteristicsindeepversuslobarintracerebralhemorrhage
AT gernerstefant hematomaenlargementcharacteristicsindeepversuslobarintracerebralhemorrhage
AT sprugelmaximiliani hematomaenlargementcharacteristicsindeepversuslobarintracerebralhemorrhage
AT roedersebastians hematomaenlargementcharacteristicsindeepversuslobarintracerebralhemorrhage
AT madzardominik hematomaenlargementcharacteristicsindeepversuslobarintracerebralhemorrhage
AT hagenmanuel hematomaenlargementcharacteristicsindeepversuslobarintracerebralhemorrhage
AT hoelterphilip hematomaenlargementcharacteristicsindeepversuslobarintracerebralhemorrhage
AT luckinghannes hematomaenlargementcharacteristicsindeepversuslobarintracerebralhemorrhage
AT dorflerarnd hematomaenlargementcharacteristicsindeepversuslobarintracerebralhemorrhage
AT schwabstefan hematomaenlargementcharacteristicsindeepversuslobarintracerebralhemorrhage
AT huttnerhagenb hematomaenlargementcharacteristicsindeepversuslobarintracerebralhemorrhage